| Income Statement | 2025-09-30 | |||
|---|---|---|---|---|
| Net revenues | 42 | |||
| Cost of goods sold | 203 | |||
| Research and development | 2,700 | |||
| Sales and marketing | 405 | |||
| General and administrative | 2,442 | |||
| Total costs and operating expenses | 5,750 | |||
| Operating loss | -5,708 | |||
| Change in fair value of forward purchase agreement warrant liability | -64 | |||
| Change in fair value of private warrant liability | 339 | |||
| Change in fair value of publicly traded warrant liability | 33 | |||
| Interest expense, related party | 471 | |||
| Other income (expense), net | 5 | |||
| Total other income (expense), net | -774 | |||
| Net loss | -6,482 | |||
| Cumulative preferred dividends | 1,265 | |||
| Net loss attributable to common stockholders, basic | -7,747 | |||
| Net loss per share attributable to common stockholders, basic (in dollars per share) | -0.35 | |||
| Net loss per share attributable to common stockholders, diluted (in dollars per share) | -0.35 | |||
| Weighted-average class a common stock outstanding, basic (in shares) | 21,851,606 | |||
| Weighted-average class a common stock outstanding, diluted (in shares) | 21,851,606 | |||
Envoy Medical, Inc. (COCHW)
Envoy Medical, Inc. (COCHW)